| scholarly article | Q13442814 |
| P356 | DOI | 10.3810/PGM.2012.01.2523 |
| P698 | PubMed publication ID | 22314120 |
| P50 | author | Alan J Wein | Q67190115 |
| P2093 | author name string | Ariana L Smith | |
| P2860 | cites work | M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland | Q34525370 |
| Muscarinic receptor antagonists for overactive bladder | Q34699525 | ||
| Weight loss: a novel and effective treatment for urinary incontinence | Q35011770 | ||
| Antimuscarinics and the overactive detrusor--which is the main mechanism of action? | Q35036554 | ||
| Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate | Q35545711 | ||
| Mild dehydration: a risk factor of constipation? | Q35610095 | ||
| Antimuscarinics for treatment of overactive bladder | Q35615145 | ||
| Behavioral treatment options for urinary incontinence | Q35673213 | ||
| New pharmacologic targets for the treatment of the overactive bladder: an update | Q35687975 | ||
| Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients | Q36362859 | ||
| Rx: Caffeine | Q36509908 | ||
| Botulinum toxin A in the overactive bladder: current status and future directions | Q36741471 | ||
| Refractory idiopathic urge urinary incontinence and botulinum A injection. | Q37004158 | ||
| The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis | Q37206637 | ||
| Current management of overactive bladder | Q37271328 | ||
| Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence | Q37325841 | ||
| Muscarinic receptor antagonists for overactive bladder treatment: does one fit all? | Q37341473 | ||
| The evaluation and treatment of nocturia: a consensus statement | Q37890031 | ||
| A review of flavoxate hydrochloride in the treatment of urge incontinence | Q38195179 | ||
| Alleviating constipation in the elderly improves lower urinary tract symptoms | Q39420158 | ||
| Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. | Q40171184 | ||
| The effects of nicotine on spontaneous contractions of cat urinary bladder in situ | Q41740819 | ||
| Efficacy of bladder training in older women with urinary incontinence | Q41824956 | ||
| Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system | Q42651945 | ||
| Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. | Q43542367 | ||
| Association of smoking with urgency in older people | Q43723532 | ||
| Caffeine reduction education to improve urinary symptoms | Q43973015 | ||
| A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders | Q44508678 | ||
| Cigarette smoking and urinary incontinence in women | Q44897546 | ||
| Obesity and lower urinary tract function in women: effect of surgically induced weight loss | Q44900699 | ||
| Caffeine: does it affect your bladder? | Q45107621 | ||
| The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study | Q45269477 | ||
| The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women | Q46417258 | ||
| Urinary habits among asymptomatic women | Q46827667 | ||
| Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics | Q46863924 | ||
| Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity | Q46906934 | ||
| Prevention of urinary incontinence by behavioral modification program: a randomized, controlled trial among older women in the community | Q47215113 | ||
| Brain pertussis toxin-sensitive G proteins are involved in the flavoxate hydrochloride-induced suppression of the micturition reflex in rats | Q48962737 | ||
| Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve. | Q51761725 | ||
| Fluid intake and urinary incontinence in older community-dwelling women. | Q52203478 | ||
| Buscopan and glaucoma: a survey of current practice. | Q52347929 | ||
| Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. | Q53248115 | ||
| The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. | Q53317478 | ||
| Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. | Q53408731 | ||
| Diuretic potential of energy drinks | Q57305801 | ||
| Risk factors for lower urinary tract symptoms in women 40 to 60 years of age | Q57731370 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 104-116 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Postgraduate Medicine | Q7234297 |
| P1476 | title | Contemporary management of overactive bladder | |
| P478 | volume | 124 |
Search more.